-
1
-
-
0004137965
-
-
Accessed February 1, 2010, Second Edition, American Psychiatric Association Steering Committee
-
Karasu TB, Gelenberg A, Merriam A, Wang P; American Psychiatric Association Steering Committee. Practice guideline for the treatment of patients with major depressive disorder. Second Edition. Available at: www.psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file= MDD2e-Inactivated-04-16-09. Accessed February 1, 2010.
-
Practice guideline for the treatment of patients with major depressive disorder
-
-
Karasu, T.B.1
Gelenberg, A.2
Merriam, A.3
Wang, P.4
-
2
-
-
0022870171
-
Noncompliance in schizophrenia
-
1:STN:280:DyaL2s3gsVSrsA%3D%3D 2883650
-
I.E. Babiker 1986 Noncompliance in schizophrenia Psychiatr Dev. 4 329 337 1:STN:280:DyaL2s3gsVSrsA%3D%3D 2883650
-
(1986)
Psychiatr Dev.
, vol.4
, pp. 329-337
-
-
Babiker, I.E.1
-
3
-
-
0036773689
-
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
-
12416599
-
J.P. Lacro L.B. Dunn C.R. Dolder S.G. Leckband D.V. Jeste 2002 Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature J Clin Psychiatry 63 892 909 12416599
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 892-909
-
-
Lacro, J.P.1
Dunn, L.B.2
Dolder, C.R.3
Leckband, S.G.4
Jeste, D.V.5
-
4
-
-
0033950999
-
Predicting medication noncompliance after hospital discharge among patients with schizophrenia
-
DOI 10.1176/appi.ps.51.2.216
-
M. Olfson D. Mechanic S. Hansell C.A. Boyer J. Walkup P.J. Weiden 2000 Predicting medication noncompliance after hospital discharge among patients with schizophrenia Psychiatr Serv. 51 216 222 1:STN:280:DC%2BD3c7itFSjtg%3D%3D 10.1176/appi.ps.51.2.216 10655006 (Pubitemid 30082525)
-
(2000)
Psychiatric Services
, vol.51
, Issue.2
, pp. 216-222
-
-
Olfson, M.1
Mechanic, D.2
Hansell, S.3
Boyer, C.A.4
Walkup, J.5
Weiden, P.J.6
-
5
-
-
0034710203
-
Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence
-
1:STN:280:DC%2BD3czptVKgug%3D%3D 10.1001/archinte.160.14.2101 10904452
-
M.R. DiMatteo H.S. Lepper T.W. Croghan 2000 Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med. 160 2101 2107 1:STN:280:DC%2BD3czptVKgug%3D%3D 10.1001/archinte.160.14.2101 10904452
-
(2000)
Arch Intern Med.
, vol.160
, pp. 2101-2107
-
-
Dimatteo, M.R.1
Lepper, H.S.2
Croghan, T.W.3
-
6
-
-
67650034173
-
Persistence and compliance to antidepressant treatment in patients with depression: A chart review
-
10.1186/1471-244X-9-38 19531229
-
N. Sawada H. Uchida T. Suzuki 2009 Persistence and compliance to antidepressant treatment in patients with depression: A chart review BMC Psychiatry 9 38 10.1186/1471-244X-9-38 19531229
-
(2009)
BMC Psychiatry
, vol.9
, pp. 38
-
-
Sawada, N.1
Uchida, H.2
Suzuki, T.3
-
7
-
-
34247572943
-
Adherence to antidepressant treatment among privately insured patients with depression
-
10.1097/01.mlr.0000254574.23418.f6 17496721
-
A. Akincigil J.R. Bowblis C. Levin J.T. Walkup S. Jan S. Crystal 2007 Adherence to antidepressant treatment among privately insured patients with depression Med Care 45 363 369 10.1097/01.mlr.0000254574.23418.f6 17496721
-
(2007)
Med Care
, vol.45
, pp. 363-369
-
-
Akincigil, A.1
Bowblis, J.R.2
Levin, C.3
Walkup, J.T.4
Jan, S.5
Crystal, S.6
-
8
-
-
33645985828
-
Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes
-
DOI 10.1097/01.mlr.0000204287.82701.9b, PII 0000565020060400000002
-
C.R. Cantrell M.T. Eaddy M.B. Shah T.S. Regan M.C. Sokol 2006 Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes Med Care 44 300 303 10.1097/01.mlr. 0000204287.82701.9b 16565629 (Pubitemid 43755432)
-
(2006)
Medical Care
, vol.44
, Issue.4
, pp. 300-303
-
-
Cantrell, C.R.1
Eaddy, M.T.2
Shah, M.B.3
Regan, T.S.4
Sokol, M.C.5
-
10
-
-
0035676124
-
Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors
-
DOI 10.1192/bjp.179.6.519
-
W.E. Meijer M.L. Bouvy E.R. Heerdink J. Urquhart H.G. Leufkens 2001 Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors Br J Psychiatry 179 519 522 1:STN:280: DC%2BD38%2FgtVOltw%3D%3D 10.1192/bjp.179.6.519 11731355 (Pubitemid 34031677)
-
(2001)
British Journal of Psychiatry
, vol.179
, Issue.DEC.
, pp. 519-522
-
-
Meijer, W.E.E.1
Bouvy, M.L.2
Heerdink, E.R.3
Urquhart, J.4
Leufkens, H.G.M.5
-
11
-
-
37349059292
-
Six-month compliance with antidepressant medication in the treatment of major depressive disorder
-
DOI 10.1097/YIC.0b013e3282f1c1d8, PII 0000485020080100000005
-
K. Demyttenaere A. Adelin P. Mesters W. Dewé K. De Bruyckere 2008 Six-month compliance with antidepressant medication in the treatment of major depressive disorder Int Clin Psychopharmacol. 23 36 42 10.1097/YIC. 0b013e3282f1c1d8 18090506 (Pubitemid 350294868)
-
(2008)
International Clinical Psychopharmacology
, vol.23
, Issue.1
, pp. 36-42
-
-
Demyttenaere, K.1
Adelin, A.2
Patrick, M.3
Walthere, D.4
Katrien, D.B.5
Michele, S.6
-
12
-
-
0029192252
-
The role of the primary care physician in patients' adherence to antidepressant therapy
-
1:STN:280:DyaK2M7itl2qug%3D%3D 10.1097/00005650-199501000-00006 7823648
-
E.H. Lin M. Von Korff W. Katon 1995 The role of the primary care physician in patients' adherence to antidepressant therapy Med Care 33 67 74 1:STN:280:DyaK2M7itl2qug%3D%3D 10.1097/00005650-199501000-00006 7823648
-
(1995)
Med Care
, vol.33
, pp. 67-74
-
-
Lin, E.H.1
Von Korff, M.2
Katon, W.3
-
13
-
-
77955451250
-
A review of the costs associated with depression and treatment noncompliance: The potential benefits of online support
-
10.1097/YIC.0b013e328339fbcf 20715299
-
A. Wade J. Häring 2010 A review of the costs associated with depression and treatment noncompliance: The potential benefits of online support Int Clin Psychopharmacol. 25 288 296 10.1097/YIC.0b013e328339fbcf 20715299
-
(2010)
Int Clin Psychopharmacol.
, vol.25
, pp. 288-296
-
-
Wade, A.1
Häring, J.2
-
14
-
-
41549105366
-
Factors affecting therapeutic compliance: A review from the patient's perspective
-
18728716
-
J. Jin G.E. Sklar V.M.S. Oh S.C. Li 2008 Factors affecting therapeutic compliance: A review from the patient's perspective Ther Clin Risk Manag. 4 269 286 18728716
-
(2008)
Ther Clin Risk Manag.
, vol.4
, pp. 269-286
-
-
Jin, J.1
Sklar, G.E.2
Oh, V.M.S.3
Li, S.C.4
-
15
-
-
77957128916
-
Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease
-
10.1093/jpepsy/jsp126 20026567
-
K.A. Hommel R.N. Baldassano 2010 Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease J Pediatr Psychol. 35 1005 1010 10.1093/jpepsy/jsp126 20026567
-
(2010)
J Pediatr Psychol.
, vol.35
, pp. 1005-1010
-
-
Hommel, K.A.1
Baldassano, R.N.2
-
16
-
-
35949002894
-
Patients' beliefs about depression and how they relate to duration of antidepressant treatment. Use of a US measurement in a UK primary care population
-
J. Lynch T. Kendrick M. Moore O. Johnston P.W.F. Smith 2006 Patients' beliefs about depression and how they relate to duration of antidepressant treatment. Use of a US measurement in a UK primary care population Primary Care Mental Health 4 207 217
-
(2006)
Primary Care Mental Health
, vol.4
, pp. 207-217
-
-
Lynch, J.1
Kendrick, T.2
Moore, M.3
Johnston, O.4
Smith, P.W.F.5
-
17
-
-
0035185660
-
Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence
-
DOI 10.1176/appi.ps.52.12.1615
-
J.A. Sirey M.L. Bruce G.S. Alexopoulos D.A. Perlick S.J. Friedman B.S. Meyers 2001 Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence Psychiatr Serv. 52 1615 1620 1:STN:280:DC%2BD3MnotVygsQ%3D%3D 10.1176/appi.ps.52.12.1615 11726752 (Pubitemid 33104454)
-
(2001)
Psychiatric Services
, vol.52
, Issue.12
, pp. 1615-1620
-
-
Sirey, J.A.1
Bruce, M.L.2
Alexopoulos, G.S.3
Perlick, D.A.4
Friedman, S.J.5
Meyers, B.S.6
-
18
-
-
78649324680
-
Society for the Advancement of Education
-
USA Today
-
Society for the Advancement of Education. Swallowing difficulties cause for concern. USA Today. 2004 Oct. Available at: http://findarticles.com/p/ articles/mi-m1272/is-2713-133/ai-n6237884/. Accessed March 12, 2010.
-
Swallowing Difficulties Cause for Concern
-
-
-
20
-
-
78649332965
-
Head and neck disorders affecting swallowing
-
McCulloch TM, Jaffe D. Head and neck disorders affecting swallowing. GI Motility online; 2006. Available at: http://www.nature.com/gimo/contents/pt1/ full/gimo36.html Accessed August 11, 2010.
-
(2006)
GI Motility Online
-
-
McCulloch, T.M.1
Jaffe, D.2
-
21
-
-
0025942085
-
Errors of deglutition - Real and imagined; Or, don't forget the psyche
-
1:STN:280:DyaK38%2FptF2nsA%3D%3D 10.1017/S0022215100117414 1753188
-
J.S. Gilbody 1991 Errors of deglutition - real and imagined; or, don't forget the psyche J Laryngol Otol. 105 807 811 1:STN:280:DyaK38%2FptF2nsA%3D%3D 10.1017/S0022215100117414 1753188
-
(1991)
J Laryngol Otol.
, vol.105
, pp. 807-811
-
-
Gilbody, J.S.1
-
22
-
-
0030112520
-
Dysphagia and emotional distress
-
1:STN:280:DyaK2s3msVSqug%3D%3D 9109970
-
O. Bretan M.A. Henry F. [. Kerr-Corrêa 1996 Dysphagia and emotional distress Arq Gastroenterol. 33 60 65 1:STN:280:DyaK2s3msVSqug%3D%3D 9109970
-
(1996)
Arq Gastroenterol.
, vol.33
, pp. 60-65
-
-
Bretan, O.1
Henry, M.A.2
Kerr-Corrêa, F.3
-
23
-
-
0034748851
-
Patients' evaluation of shape, size and colour of solid dosage forms
-
DOI 10.1023/A:1012050931018
-
A.B. Overgaard J. Hojsted R. Hansen J. Moller-Sonnergaard L.L. Christup 2001 Patients' evaluation of shape, size and colour of solid dosage forms Pharm World Sci. 23 185 188 1:STN:280:DC%2BD3Mnns1agsw%3D%3D 10.1023/A:1012050931018 11721676 (Pubitemid 33027102)
-
(2001)
Pharmacy World and Science
, vol.23
, Issue.5
, pp. 185-188
-
-
Overgaard, A.B.A.1
Moller-Sonnergaard, J.2
Christrup, L.L.3
Hojsted, J.4
Hansen, R.5
-
24
-
-
0037014375
-
Medication administration in nursing homes
-
12216309
-
D. Wright 2002 Medication administration in nursing homes Nurs Stand. 16 33 38 12216309
-
(2002)
Nurs Stand.
, vol.16
, pp. 33-38
-
-
Wright, D.1
-
25
-
-
33746095382
-
Prevalence of dysphagia in acute and community mental health settings
-
DOI 10.1007/s00455-006-9016-9
-
J. Regan R. Sowman I. Walsh 2006 Prevalence of dysphagia in acute and community mental health settings Dysphagia 21 95 101 1:STN:280: DC%2BD28vntFSqug%3D%3D 10.1007/s00455-006-9016-9 16763936 (Pubitemid 44078541)
-
(2006)
Dysphagia
, vol.21
, Issue.2
, pp. 95-101
-
-
Regan, J.1
Sowman, R.2
Walsh, I.3
-
26
-
-
34249293341
-
The patient-physician relationship in the approach to therapeutic management
-
DOI 10.1007/s10072-007-0765-5
-
G.C. Manzoni P. Torelli 2007 The patient-physician relationship in the approach to therapeutic management Neurol Sci. 28 suppl.2 S130 S133 10.1007/s10072-007-0765-5 17508159 (Pubitemid 46813641)
-
(2007)
Neurological Sciences
, vol.28
, Issue.SUPPL. 2
-
-
Manzoni, G.C.1
Torelli, P.2
-
27
-
-
18744386141
-
Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies
-
DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10
-
Y. Fu Y. Schicheng S.H. Jeong S. Kimura K. Park 2004 Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies Crit Rev Ther Drug Carrier Syst. 21 433 475 1:CAS:528: DC%2BD2MXltlWgsbs%3D 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10 15658933 (Pubitemid 41647575)
-
(2004)
Critical Reviews in Therapeutic Drug Carrier Systems
, vol.21
, Issue.6
, pp. 433-475
-
-
Fu, Y.1
Yang, S.2
Jeong, S.H.3
Kimura, S.4
Park, K.5
-
28
-
-
72749112604
-
Formulation design and optimization of fast dissolving clonazepam tablets
-
1:STN:280:DC%2BC3czmsVeqsA%3D%3D 10.4103/0250-474X.58189 20502581
-
S.B. Shirsand S. Suresh O.V. Swamy 2009 Formulation design and optimization of fast dissolving clonazepam tablets Indian J Pharm Sci. 71 567 572 1:STN:280:DC%2BC3czmsVeqsA%3D%3D 10.4103/0250-474X.58189 20502581
-
(2009)
Indian J Pharm Sci.
, vol.71
, pp. 567-572
-
-
Shirsand, S.B.1
Suresh, S.2
Swamy, O.V.3
-
29
-
-
34249301019
-
Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet
-
DOI 10.1080/03639040601150237, PII 778978621
-
I.S. Ahmed F.A. Fatahalla 2007 Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet Drug Dev Ind Pharm. 33 505 511 1:CAS:528:DC%2BD2sXlsFChsrY%3D 10.1080/ 03639040601150237 17520441 (Pubitemid 46808770)
-
(2007)
Drug Development and Industrial Pharmacy
, vol.33
, Issue.5
, pp. 505-511
-
-
Ahmed, I.S.1
Fatahalla, F.A.2
-
30
-
-
17644384451
-
Pharmacokinetic profiles of two tablet formulations of piroxicam
-
DOI 10.1016/j.ijpharm.2005.02.006
-
C. Rasetti-Escargueil V. Grangé 2005 Pharmacokinetic profiles of two tablet formulations of piroxicam Int J Pharm. 296 129 134 10.1016/j.ijpharm.2005.02.006 (Pubitemid 40558796)
-
(2005)
International Journal of Pharmaceutics
, vol.295
, Issue.1-2
, pp. 129-134
-
-
Rasetti-Escargueil, C.1
Grange, V.2
-
32
-
-
0018840433
-
Fear of choking and its treatment. A behavioural approach
-
1:STN:280:DyaL3c7ns1OjtA%3D%3D 6102887
-
L. Solyom D. Sookman 1980 Fear of choking and its treatment. A behavioural approach Can J Psychiatry 25 30 34 1:STN:280:DyaL3c7ns1OjtA%3D%3D 6102887
-
(1980)
Can J Psychiatry
, vol.25
, pp. 30-34
-
-
Solyom, L.1
Sookman, D.2
-
33
-
-
70349861743
-
Choking phobia: Full remission following behavior therapy
-
10.1590/S1516-44462009005000002 19787155
-
S. Scemes R.C. Wielenska M.A. Savoia M. Bernik 2009 Choking phobia: Full remission following behavior therapy Rev Bras Psiquiatr. 31 257 260 10.1590/S1516-44462009005000002 19787155
-
(2009)
Rev Bras Psiquiatr.
, vol.31
, pp. 257-260
-
-
Scemes, S.1
Wielenska, R.C.2
Savoia, M.A.3
Bernik, M.4
-
34
-
-
78649335316
-
Difficult to swallow: Patient preferences for alternative valproate pharmaceutical formulations
-
10.2147/PPA.S5691 19936158
-
M. Bhosle J.S. Benner M. DeKoven J. Shelton 2009 Difficult to swallow: Patient preferences for alternative valproate pharmaceutical formulations Patient Prefer Adherence 3 161 171 10.2147/PPA.S5691 19936158
-
(2009)
Patient Prefer Adherence
, vol.3
, pp. 161-171
-
-
Bhosle, M.1
Benner, J.S.2
Dekoven, M.3
Shelton, J.4
-
35
-
-
23844462862
-
Part IV: Effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: A post-marketing surveillance study in Germany
-
DOI 10.1185/030079905X46296
-
H.C. Diener A. Gendolla 2005 Part IV: Effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: A postmarketing surveillance study in Germany Curr Med Res Opin. 21 suppl.3 S18 24 1:CAS:528:DC%2BD2MXhtFKktbzO 10.1185/030079905X46296 16083520 (Pubitemid 41152959)
-
(2005)
Current Medical Research and Opinion, Supplement
, vol.21
, Issue.3
-
-
Diener, H.-C.1
Gendolla, A.2
-
36
-
-
0141725778
-
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet
-
1:CAS:528:DC%2BD3sXotl2jsb4%3D 14529055
-
A.J. Dowson B.R. Charlesworth 2003 Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet Int J Clin Pract. 57 573 576 1:CAS:528:DC%2BD3sXotl2jsb4%3D 14529055
-
(2003)
Int J Clin Pract.
, vol.57
, pp. 573-576
-
-
Dowson, A.J.1
Charlesworth, B.R.2
-
37
-
-
34948889170
-
Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease: ACCEPTO study
-
10.2165/00044011-200727110-00003 17914895
-
C.M. de Argila J. Ponce E. Márquez 2007 Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease: ACCEPTO study Clin Drug Investig. 27 765 770 10.2165/00044011-200727110-00003 17914895
-
(2007)
Clin Drug Investig.
, vol.27
, pp. 765-770
-
-
De Argila, C.M.1
Ponce, J.2
Márquez, E.3
-
38
-
-
67650090764
-
A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS study
-
1:STN:280:DC%2BD1MvotFSjtw%3D%3D 10.1016/j.schres.2009.05.024 19535229
-
J. Karagianis L. Grossman J. Landry 2009 A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS study Schizophr Res. 113 41 48 1:STN:280:DC%2BD1MvotFSjtw%3D%3D 10.1016/j.schres.2009.05.024 19535229
-
(2009)
Schizophr Res.
, vol.113
, pp. 41-48
-
-
Karagianis, J.1
Grossman, L.2
Landry, J.3
-
39
-
-
59849119668
-
Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet
-
10.1620/tjem.216.249 18987459
-
N. Koh S. Sakamoto F. Chino 2008 Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet Tohoku J Exp Med. 216 249 257 10.1620/tjem.216.249 18987459
-
(2008)
Tohoku J Exp Med.
, vol.216
, pp. 249-257
-
-
Koh, N.1
Sakamoto, S.2
Chino, F.3
-
40
-
-
39749203478
-
Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary care
-
DOI 10.1185/030079908X261104
-
E. Márquez-Contreras V. Gil J. López 2008 Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary care Curr Med Res Opin. 24 569 576 10.1185/030079908X261104 18194594 (Pubitemid 351294405)
-
(2008)
Current Medical Research and Opinion
, vol.24
, Issue.2
, pp. 569-576
-
-
Marquez-Contreras, E.1
Gil, V.2
Lopez, J.3
Plazas, M.J.4
Heras, J.5
Galvan, J.6
Porcel, J.7
-
41
-
-
49849089222
-
Olanzapine orally disintegrating tablet: A review of efficacy and compliance
-
1:CAS:528:DC%2BD1cXhtFentLvK 10.1111/j.1755-5949.2008.00053.x 18801113
-
L. San M. Csillas A. Ciudad I. Gilaberte 2008 Olanzapine orally disintegrating tablet: A review of efficacy and compliance CNS Neurosci Ther. 14 203 214 1:CAS:528:DC%2BD1cXhtFentLvK 10.1111/j.1755-5949.2008.00053.x 18801113
-
(2008)
CNS Neurosci Ther.
, vol.14
, pp. 203-214
-
-
San, L.1
Csillas, M.2
Ciudad, A.3
Gilaberte, I.4
-
43
-
-
34447498650
-
Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia [1]
-
DOI 10.1097/01.jcp.0000264986.32733.df, PII 0000471420070800000012
-
H. Lieu-Seifert J. Houston D. Adams B.J. Kinon 2007 Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia J Clin Psychopharmacol. 27 392 394 10.1097/01.jcp.0000264986.32733.df (Pubitemid 47075511)
-
(2007)
Journal of Clinical Psychopharmacology
, vol.27
, Issue.4
, pp. 392-394
-
-
Liu-Seifert, H.1
Houston, J.P.2
Adams, D.H.3
Kinon, B.J.4
-
44
-
-
33748299609
-
Improving medication adherence with orally disintegrating tablets
-
16951598
-
G. Uko-Ekpenyong 2006 Improving medication adherence with orally disintegrating tablets Nursing 36 20 21 16951598
-
(2006)
Nursing
, vol.36
, pp. 20-21
-
-
Uko-Ekpenyong, G.1
-
45
-
-
28844435374
-
Orally disintegrating antipsychotics may promote compliance and adherence in patients with schizophrenia
-
10.4088/JCP.v66n1121e 16420093
-
F.L. Tornatore 2005 Orally disintegrating antipsychotics may promote compliance and adherence in patients with schizophrenia J Clin Psychiatry 66 1493 1494 10.4088/JCP.v66n1121e 16420093
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 1493-1494
-
-
Tornatore, F.L.1
-
46
-
-
33845419519
-
Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets
-
DOI 10.1055/s-2006-950498
-
C. Normann M. Schmauss N. Bakri M. Gerwe A. Schreiner 2006 Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets Pharmacopsychiatry 39 209 212 1:CAS:528:DC%2BD2sXhs1yqtr0%3D 10.1055/s-2006-950498 17124642 (Pubitemid 44899721)
-
(2006)
Pharmacopsychiatry
, vol.39
, Issue.6
, pp. 209-212
-
-
Normann, C.1
Schmauss, M.2
Bakri, N.3
Gerwe, M.4
Schreiner, A.5
-
47
-
-
33749317195
-
Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older
-
DOI 10.1002/gps.1589
-
J.C. Nelson S.B. Hollander J. Betzel P. f. t. Smolen Mirtazapine Nursing Home Study Group 2006 Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older Int J Geriatr Psychiatry 21 898 901 10.1002/gps.1589 16955423 (Pubitemid 44492564)
-
(2006)
International Journal of Geriatric Psychiatry
, vol.21
, Issue.9
, pp. 898-901
-
-
Nelson, J.C.1
Hollander, S.B.2
Betzel, J.3
Smolen, P.4
Agronin, M.5
Bermingham, R.6
Bertino, J.7
Chess, D.8
Cranmer, K.9
Detrinis, R.10
Gelman, L.11
Hawa, J.12
Irvin, E.C.13
Kopyt, N.14
Levy, M.15
Marchello, V.16
Miller, L.17
Reddy-Pasem, S.18
Rapp, K.19
Rosanwo, A.20
Salzman, C.21
Segal, S.22
Shepard, M.23
Siegal, A.24
Tomas, D.25
Usher, L.26
Watt, C.K.27
more..
-
48
-
-
0344413673
-
Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home
-
DOI 10.1185/030079903125002441
-
S.P. Roose J.C. Nelson C. Salzman S.B. Hollander H. f. t. Rodrigues Mirtazapine in the Nursing Home Study Group 2003 Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home Curr Med Res Opin. 19 737 746 10.1185/030079903125002441 14687445 (Pubitemid 37466144)
-
(2003)
Current Medical Research and Opinion
, vol.19
, Issue.8
, pp. 737-746
-
-
Roose, S.P.1
Nelson, J.C.2
Salzman, C.3
Hollander, S.B.4
Rodrigues, H.5
-
49
-
-
0043135289
-
Mirtazapine orally disintegrating tablet versus sertraline: A prospective onset of action study
-
DOI 10.1097/01.jcp.0000085408.08426.05
-
K. Behnke J. Søgaard S. Martin 2003 Mirtazapine orally disintegrating tablet versus sertraline: A prospective onset of action study J Clin Psychopharmacol. 23 358 364 1:CAS:528:DC%2BD3sXmt1Ohtr8%3D 10.1097/01.jcp.0000085408.08426.05 12920411 (Pubitemid 36951177)
-
(2003)
Journal of Clinical Psychopharmacology
, vol.23
, Issue.4
, pp. 358-364
-
-
Behnke, K.1
Sogaard, J.2
Martin, S.3
Bauml, J.4
Ravindran, A.V.5
Agren, H.6
Vester-Blokland, E.D.7
-
50
-
-
31544450244
-
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: A double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder
-
DOI 10.1097/01.jcp.0000194622.99986.d6
-
O. Benkert A. Szegedi M. Philipp 2006 Mirtazapine orally disintegrating tablets versus venlafaxine extended release: A double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder J Clin Psychopharmacol. 26 75 78 1:CAS:528:DC%2BD28XhsFGhtr0%3D 10.1097/01.jcp.0000194622.99986.d6 16415711 (Pubitemid 43167095)
-
(2006)
Journal of Clinical Psychopharmacology
, vol.26
, Issue.1
, pp. 75-78
-
-
Benkert, O.1
Szegedi, A.2
Philipp, M.3
Kohnen, R.4
Heinrich, C.5
Heukels, A.6
Van Der Vegte-Senden, M.7
Baker, R.A.8
Simmons, J.H.9
Schutte, A.-J.10
-
51
-
-
67249134483
-
Treating depression with different galenical drug formulations: Does it make a difference? the comparison of mirtazapine fast dissolving formulation (FDT) with conventional mirtazapine tablets (CT)
-
1:CAS:528:DC%2BD1MXlslChsb0%3D 10.1080/13651500802485262
-
A. Delini-Stula H. van Oers A. van Willigenburg B. Oddens A.-J. Schutte E. van der Meulen 2009 Treating depression with different galenical drug formulations: Does it make a difference? The comparison of mirtazapine fast dissolving formulation (FDT) with conventional mirtazapine tablets (CT) Int J Psychiatry Clin Pract. 13 109 116 1:CAS:528:DC%2BD1MXlslChsb0%3D 10.1080/13651500802485262
-
(2009)
Int J Psychiatry Clin Pract.
, vol.13
, pp. 109-116
-
-
Delini-Stula, A.1
Van Oers, H.2
Van Willigenburg, A.3
Oddens, B.4
Schutte, A.-J.5
Van Der Meulen, E.6
-
52
-
-
33745096263
-
The results of the Swiss observational study of the new, fast-dissolving mirtazapine formulation in depressed patients
-
DOI 10.1080/13651500600579175, PII G34176288737
-
A. Delini-Stula R. Bischof 2006 The results of the Swiss observational study of the new, fast-dissolving mirtazapine formulation in depressed patients Int J Psychiatry Clin Pract. 10 124 130 1:CAS:528:DC%2BD28XmvV2jsLk%3D 10.1080/13651500600579175 (Pubitemid 43879977)
-
(2006)
International Journal of Psychiatry in Clinical Practice
, vol.10
, Issue.2
, pp. 124-130
-
-
Delini-Stula, A.1
Bischof, R.2
-
54
-
-
64349093528
-
Selective serotonin reuptake inhibitors
-
S.H. Preskorn H.P. Feighner C.Y. Stanga R. Ross (eds). Springer Berlin
-
Preskorn SH, Ross R, Stanga CY. Selective serotonin reuptake inhibitors. In: Preskorn SH, Feighner HP, Stanga CY, Ross R, editors. Antidepressants: Past, present and future. Berlin: Springer; 2004; 241-262.
-
(2004)
Antidepressants: Past, Present and Future
, pp. 241-262
-
-
Preskorn, S.H.1
Ross, R.2
Stanga, C.Y.3
-
55
-
-
60849086169
-
Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple treatment meta-analysis
-
1:CAS:528:DC%2BD1MXisVOrtr8%3D 10.1016/S0140-6736(09)60046-5 19185342
-
A. Cipriani T.A. Furukawa G. Salanti 2009 Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple treatment meta-analysis Lancet 373 746 758 1:CAS:528:DC%2BD1MXisVOrtr8%3D 10.1016/S0140-6736(09)60046-5 19185342
-
(2009)
Lancet
, vol.373
, pp. 746-758
-
-
Cipriani, A.1
Furukawa, T.A.2
Salanti, G.3
|